Author

William R. Marshall

Institutions: University of Manchester, Northern Care Alliance NHS Foundation Trust

Observed institutions: University of Manchester, Northern Care Alliance NHS Foundation Trust

ORCID: 0009-0004-4764-8944

Observed ORCID: 0009-0004-4764-8944

OpenAlex ID: A5132620787

Beyond eGFR and Albuminuria: Biological Pathways and Multiomics in Cardiovascular–Kidney–Metabolic Disease

2026 · William R. Marshall, Thomas McDonnell, et al. · Kidney International Reports · 9

Metabolic syndrome and kidney dysfunction: emerging molecular and cellular mechanisms at the metabolic–renal interface

2026 · William R. Marshall, Darren Green, et al. · Frontiers in Endocrinology · 5

Evaluating PREVENT for Cardiokidney Outcomes in CKD

2026 · William R. Marshall, Thomas McDonnell, et al. · Clinical Journal of the American Society of Nephrology · 1

Response to the Letter to the Editor Entitled “From Molecular Signal to Clinical Action in Cardiovascular-Kidney-Metabolic Disease 2”

2026 · William R. Marshall, Thomas McDonnell, et al. · Kidney International Reports · 1

Cardiovascular-Kidney-Metabolic Multimorbidity Burden and Phenotype Differentially Influence Cardiovascular and Renal Risk in Advanced Chronic Kidney Disease

2026 · William R. Marshall, Rajkumar Chinnadurai, et al. · Cardiorenal Medicine · 1

Response to the Letter to the Editor Entitled “Keeping Clinical CKM Staging Distinct From Biological Enrichment”

2026 · William R. Marshall · Kidney International Reports

Real-World Effectiveness of Targeted-Release Budesonide in IgA Nephropathy with Near-Universal SGLT2 Inhibitor Use

2026 · Thomas McDonnell, William R. Marshall, et al. · American Journal of Nephrology

Integrating the liver into the cardiovascular-kidney-metabolic syndrome: pathophysiology and therapeutic implications

2026 · William R. Marshall, Smeeta Sinha, et al. · Current Opinion in Nephrology & Hypertension

Patient Characteristics and Clinical Outcomes in a Specialist Hypertension Clinic: A Pragmatic Real‐World Single‐Center Observational Study

2026 · William R. Marshall, Henry H. L. Wu, et al. · Journal of Clinical Hypertension

Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Real-World Insights from a Propensity Score Weighted Retrospective Cohort Study

2026 · William R. Marshall, Rajkumar Chinnadurai, et al. · American Journal of Nephrology

Works count: 10

Citation count: 17

H-index: 2

I10-index: